| Title |
Juvenile Idiopathic Arthritis: Diagnosis and Treatment
|
|---|---|
| Published in |
Rheumatology and Therapy, August 2016
|
| DOI | 10.1007/s40744-016-0040-4 |
| Pubmed ID | |
| Authors |
Gabriella Giancane, Alessandro Consolaro, Stefano Lanni, Sergio Davì, Benedetta Schiappapietra, Angelo Ravelli |
| Abstract |
Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct presentation, clinical manifestations, and, presumably, genetic background and etiopathogenesis. Although none of the available drugs has curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of the biologic medications, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms related to the immune response and inflammatory process, and by the development of new drugs that are capable of selectively inhibiting single molecules or pathways. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 1 | 17% |
| Colombia | 1 | 17% |
| Bulgaria | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 3 | 50% |
| Members of the public | 2 | 33% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 402 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | <1% |
| Unknown | 401 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 66 | 16% |
| Student > Master | 40 | 10% |
| Other | 31 | 8% |
| Student > Postgraduate | 30 | 7% |
| Researcher | 29 | 7% |
| Other | 65 | 16% |
| Unknown | 141 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 166 | 41% |
| Biochemistry, Genetics and Molecular Biology | 17 | 4% |
| Nursing and Health Professions | 14 | 3% |
| Immunology and Microbiology | 11 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 2% |
| Other | 32 | 8% |
| Unknown | 154 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#1,246,369
of 25,870,142 outputs
Outputs from Rheumatology and Therapy
#21
of 593 outputs
Outputs of similar age
#22,978
of 371,191 outputs
Outputs of similar age from Rheumatology and Therapy
#1
of 7 outputs
Altmetric has tracked 25,870,142 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 593 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them